About CanniOasis
CanniOasis is a company based in Singapore (Singapore) founded in 2021 by David Jacob was acquired by Compass Ventures Group in October 2024. CanniOasis operates in a competitive market with competitors including DNAnexus, Cytel, Metagenomi, Ampersand and Octant, among others.
- Headquarter Singapore, Singapore
- Founders David Jacob
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Compass Ventures Group
(Oct 18, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CanniOasis
Detailed funding history for CanniOasis
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in CanniOasis
CanniOasis has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Compass Ventures Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Compass Ventures Group is engaged in technology and innovation services.
|
Locked | Locked | Locked |
Investor details for CanniOasis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CanniOasis
Investment portfolio details for CanniOasis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CanniOasis
Detailed financials for CanniOasis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cannioasis Comparisons
Peer comparison for CanniOasis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CanniOasis
CanniOasis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DNAnexus, Cytel, Metagenomi, Ampersand and Octant, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based genome informatics and data management are provided.
|
|
| Locked | Locked | Locked |
Data analysis and statistical solutions are provided for life sciences.
|
|
| Locked | Locked | Locked |
Next-generation gene editing tools are developed for drug enhancement.
|
|
| Locked | Locked | Locked |
Programmable medicines are developed to target and treat multiple diseases.
|
|
| Locked | Locked | Locked |
Human cell interaction platform is provided for drug discovery.
|
|
| Locked | Locked | Locked |
Bioinformatics platform for precision medicine development is offered.
|
Detailed competitors of CanniOasis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cannioasis
Complete news archive for CanniOasis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CanniOasis
CanniOasis was founded in 2021.
CanniOasis is headquartered in Singapore, Singapore.
CanniOasis was founded in 2021 in Singapore. Precision cannabinoid-based drugs for neurological disorders are developed through an AI-based theragnostic platform. MicroRNA and epigenetics are utilized to build proprietary drug screening platforms for cannabinoid treatments. Operations are centered in the biotechnology sector, with a focus on neurological diseases. The company is led by co-founder David Jacob, and activities are based in Singapore.
CanniOasis's top competitors include DNAnexus, Cytel and Relation Therapeutics.
CanniOasis has 1 investor. Key investors include Compass Ventures Group.